Grupo Espanol de Tumores Neuroendocrinos

NCT05918302

Phase 3, Recruiting, 2023, 170 people, 26 Jun 2023, clinicaltrials.gov

NCT02806648

Phase 2, Completed, 2015, 21 people, 20 Jun 2016, clinicaltrials.gov

NCT02246127

Phase 3, Completed, 2014, 141 people, 22 Sept 2014, clinicaltrials.gov

NCT01567488

Phase 2, Completed, 2011, 43 people, 30 Mar 2012, clinicaltrials.gov